Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 14;35(49 Pt B):6893-6897.
doi: 10.1016/j.vaccine.2017.09.019. Epub 2017 Nov 11.

Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine

Kelly Stefano Cole  1 , Judith M Martin  2 , William T Horne  2 , Chyongchiou J Lin  3 , Mary Patricia Nowalk  3 , John F Alcorn  2 , Richard K Zimmerman  4
Affiliations

Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine

Kelly Stefano Cole et al. Vaccine. .

Abstract

Background: In recent influenza seasons, the live attenuated influenza vaccine (LAIV) has not demonstrated the same level of vaccine effectiveness as that observed among children who received the inactivated influenza vaccine (IIV). To better understand this difference, this study compared the mRNA sequencing transcription profile (RNA seq) in children who received either IIV or LAIV.

Methods: Children 3-17years of age receiving quadrivalent influenza vaccine were enrolled. Blood samples were collected on Day 0 prior to vaccination and again on Day 7 (range 6-10days) following vaccination. Total RNA was isolated from PAXgene tubes and sequenced for a custom panel of 89 transcripts using the TruSeq Targeted RNA Expression method. Fold differences in normalized RNA seq counts from Day 0 to Day 7 were calculated, log2 transformed and compared between the two vaccine groups.

Results: Of 72 children, 46 received IIV and 26 received LAIV. Following IIV vaccination, 7 genes demonstrated significant differential expression at Day 7 (down-regulated). In contrast, following LAIV vaccination, 8 genes demonstrated significant differential expression at Day 7 (5 up-regulated and 3 down-regulated). Only two genes demonstrated similar patterns of regulation in both groups.

Conclusions: Differential regulation of genes was observed between 2015-16 LAIV and IIV recipients. These results help to elucidate the immune response to influenza vaccines and may be related to the difference in vaccine effectiveness observed in recent years between LAIV and IIV.

Keywords: Antibodies; Influenza vaccine; RNA sequencing.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest: Drs. Zimmerman has research funding from Sanofi Pasteur, Inc. Pfizer, Inc. and Merck & Co., Inc. Dr. Lin has research funding from Sanofi Pasteur, Inc. and Merck & Co, Inc. Dr. Nowalk has research funding from Pfizer, Inc. and Merck & Co., Inc. Dr. Alcorn has research funding from MedImmune, LLC and Merck & Co.

Figures

Figure 1
Figure 1. Heat maps of RNA-seq responses to IIV and LAIV
Heat maps representing differential expression of genes between Day 0 (pre) and Day 7 (post) vaccination based on P<0.05. IIV = inactivated influenza vaccine; LAIV = live attenuated influenza vaccine
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States. The Journal of infectious diseases. 2016 - PMC - PubMed
    1. Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clinical Infectious Diseases. 2016;63(12):1564–1573. - PMC - PubMed
    1. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, et al. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates. Clinical Infectious Diseases. 2014;58(3):319–327. - PMC - PubMed
    1. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious diseases. 2012;12(1):36–44. - PubMed
    1. Cotter CR, Jin H, Chen Z. A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS pathogens. 2014;10(1):e1003831. - PMC - PubMed

MeSH terms